摘要
目的探讨Avastin联合曲安奈德玻璃体腔注射治疗视网膜分支静脉阻塞(branch retinal vein occlusion,BRVO)伴黄斑水肿(macular edema,ME)的临床效果。方法选取2007年6月至12月我院门诊就诊的BRVO伴ME患者34例(35眼),玻璃体腔Avastin(20g·L-1)、曲安奈德(40g·L-1)联合注射,观察并记录视力、眼压、ME和新生血管情况。结果术后1个月,ME明显减轻30眼,无变化5眼;术后4个月,视力提高25眼,无变化6眼,下降4眼;术后6个月,视网膜新生血管减少33眼,无变化2眼。结论Avastin联合曲安奈德玻璃体腔注射治疗BRVO临床效果良好、安全稳定、无明显副作用。
Objective To evaluate the clinical effect of intravitreal injection of Avastin combined with triamcinolone acetonide （TA） for treatment of branch retinal vein occlusion （BRVO） with macttlar edema（ME）. Methods Thirty-four cases with BRVO and ME in our outpatient department from June 2007 to December 2007 were treated with intravitreal injection of Avastin （ 20 g · L^- 1 ） and TA （ 40 g · L^- 1 ）. The intraocular pressure ,visual acuity and the condition of ME ,neovascularization were investigated. Results One month after the surgery,the symptom of ME was taken a favorite turn in 30 eyes, 5 eyes with no improvement. Four months after the surgery, the visual acuity was improved in 25 eyes, 5 eyes with no change, and 4 eyes lowered. Six months after the surgery, retinal neovascularization decreased in 33 eyes,2 eyes with no change. Conclusion The intravitreal injection of Avastin and TA is a safe method to treat BRVO with favorable clinical effect, and without obviously side effect.
出处
《眼科新进展》
CAS
北大核心
2009年第2期124-125,127,共3页
Recent Advances in Ophthalmology
